News
News, talks and media.
-
mTOR fundraising campaign reaches goal
Rapamycin Longevity Labs and Ora Biomedical have reached the funding goal for a lifespan analysis of 601 mTOR modulators, the largest to date.
-
Ben Blue, PhD, featured on the NUS Healthy Longevity lecture series
Ora co-founders Brian Kennedy and Ben Blue discuss Ora’s ongoing work.
-
Ora CEO Ben Blue featured on Siim Land’s podcast
Ben Blue, PhD, talks with Siim Land about Ora Biomedical’s mission to develop novel therapeutics that target the molecular biology of aging.